Vote Scores

Home / Companies / Xenon Pharmaceuticals Inc. / 4 Jun 2024

Meeting · year to 30 June 2024319 filers reporting

Xenon Pharmaceuticals Inc.: meeting of 4 Jun 2024

Votes reported on Form N-PX, item by item

319 Form N-PX filers reported votes at the Xenon Pharmaceuticals Inc. meeting of 4 Jun 2024. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

8 nominees; 96.4% of reported votes for; 21 filers withheld from or voted against at least one nominee.

1,544 vote records from 116 filers. 1 of the 116 filers that marked the item either way voted against management.

99.1% for0.9% against0.9% against management116 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

441 vote records from 318 filers. 22 of the 305 filers that marked the item either way voted against management. 13 filers reported this item without a management mark.

88.7% for6.3% against5.0% other7.2% against management318 filers98.3% for1.7% against0.0% other1.7% against management88,736,746 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

386 vote records from 116 filers. 1 of the 116 filers that marked the item either way voted against management.

98.3% for0.0% against1.7% other0.9% against management116 filers99.9% for0.0% against0.1% other0.1% against management51,659,162 reported shares
4

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

195 vote records from 118 filers. 7 of the 118 filers that marked the item either way voted against management.

94.1% for5.1% against0.8% other5.9% against management118 filers97.3% for2.7% against0.0% other2.7% against management25,830,048 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalForForFor
State Street and SPDRForForFor
American CenturyForForFor
Franklin TempletonForForFor
InvescoForForFor
EquitableForForFor
Charles SchwabNo reportForNo report
Nuveen and TIAANo reportForNo report
ProShares and ProFundsForForFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertForForFor
J.P. MorganNo reportForNo report
Goldman SachsForForFor
PGIM and PrudentialForForFor
Jackson National fundsForForFor
Northern Trust and FlexSharesForForFor
SEINo reportForNo report
T. Rowe PriceForForFor
ThriventForForFor
Lincoln FinancialForForFor
First TrustForForFor
Russell InvestmentsForForFor
Victory CapitalForForFor
Brighthouse FundsForForFor
BNY MellonForAgainst *For
PrincipalForForFor
Capital Group and American FundsForForFor
Pacific Life fundsForForFor
Federated HermesForForFor
AllianceBernsteinForForFor
Hartford FundsForForFor
MassMutualForForFor
Harbor FundsForForFor
Janus HendersonForForFor
Neuberger BermanNo reportForNo report
Natixis and Loomis SaylesForForFor
Lord AbbettForForFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Xenon Pharmaceuticals Inc. meeting?

319 Form N-PX filers reported votes at the meeting of 4 Jun 2024. On say-on-pay, 22 of 305 voted against management (7.2%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Xenon Pharmaceuticals Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Xenon Pharmaceuticals Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Xenon Pharmaceuticals Inc. with a meeting date within three days of 4 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.